Time for a change in drug pricing: Going downstream - Comment on Drummond's short paper

European Journal of Health Economics

Volumn 3, Issue 2, 2002, Pages 140-142

  De Pouvourville, G ^a   Lekkerkerker, F ^b,c   Rutten, F ^d   Drummond, M ^e  

^a INSERM   (France)

^b MEDICINES EVALUATION BOARD   (Netherlands)

^c EUROPEAN MEDICINES AGENCY   (United Kingdom)

^d ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^e UNIVERSITY OF YORK   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT;

ANTIBIOTIC THERAPY; COST EFFECTIVENESS ANALYSIS; DRUG COST; DRUG INDUSTRY; FRANCE; HEALTH CARE DELIVERY; HUMAN; NOTE; PRACTICE GUIDELINE; PRESCRIPTION; PRIORITY JOURNAL; UNITED KINGDOM;

EID: 0036960038     PISSN: 16187598     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10198-002-0122-9     Document Type: Note

References (0)